Bill Sponsor
House Bill 1222
115th Congress(2017-2018)
Congenital Heart Futures Reauthorization Act of 2017
Became Law
Amendments
Became Law
Became Public Law 115-342 on Dec 21, 2018
Overview
Text
Introduced
Feb 27, 2017
Latest Action
Dec 21, 2018
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
1222
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
House Votes (2)
Senate Votes (1)
Question
On Motion to Suspend the Rules and Concur in the Senate Amendment
Status
Passed
Type
Roll Call Vote
Roll Call Vote
A vote that records the individual position of each Member who voted. Such votes occurring on the House floor (by the "yeas and nays" or by "recorded vote") are taken by electronic device. The Senate has no electronic voting system; in such votes, Senators answer "yea" or "nay" as the clerk calls each name aloud. Each vote is compiled by clerks and receives a roll call number (referenced in Congress.gov as a "Record Vote" [Senate] or "Roll no." [House]).
Roll Call Type
2/3 Yea-And-Nay
Roll Number
436
House Roll Call Votes
Summary

Congenital Heart Futures Reauthorization Act of 2017

This bill amends the Public Health Service Act to replace the authorization for a National Congenital Heart Disease Surveillance System with a requirement for the Department of Health and Human Services, regarding congenital heart disease, to enhance and expand research and surveillance infrastructure, and plan and implement a public outreach and education campaign. (Congenital heart disease is a condition caused by a heart defect that is present at birth.)

The Centers for Disease Control and Prevention must award grants to nonprofit entities to conduct: (1) a study of congenital heart disease, from birth to adulthood, that considers health care utilization, demographic factors, and outcomes; and (2) an awareness, outreach, and education campaign regarding congenital heart disease. Data from the study must be made available to the public.

The National Heart, Lung, and Blood Institute must report on its ongoing research efforts regarding congenital heart disease, future plans for such research, and areas of greatest need for such research.

Text (7)
August 15, 2018
February 27, 2018
February 26, 2018
September 25, 2017
February 27, 2017
Amendments (1)
Dec 12, 2018
Agreed to in Senate
2
Sponsorship
Senate Amendment 4103
In the nature of a substitute.
Agreed To
Public Record
Record Updated
Mar 22, 2023 7:50:50 PM